London, UK – LGC has today announced that Joydeep Goswami is joining its Board of Directors and Executive Leadership Team (ELT) as President and Chief Executive Officer (CEO). Joydeep succeeds Euan O’Sullivan, who decided to step down from his role in early 2024 after fourteen years of outstanding and dedicated service. Euan has worked closely with […]
ResolveSEQ MRD offers paired single cell genome and transcriptome characterization for discovering novel prognostic and therapeutic signatures in MRD cells New Certified Service Provider (CSP) Program will enable broader access to BioSkryb’s technology Durham, N.C. – BioSkryb Genomics, a pioneer in single-cell and ultra-low input multiomics is excited to announce the launch of ResolveSEQ MRD, an […]
Appointment signals acceleration of organic and inorganic growth for VION as it looks to expand in 2025 CHARLOTTESVILLE, Va. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, today announced Vince Stoyanov as its Chief Strategy and Development Officer. He will lead […]
Berry Genomics will leverage PacBio Vega System to develop long-read sequencing-based solutions for patients in China and other countries MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, has delivered its first Vega systems to Berry Genomics as part of an early access agreement announced in 2022. Under the terms […]
Regulatory automation platform eases the burden of documenting NGS workflows Vienna, Austria and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, and regulatory automation provider Platomics are collaborating to streamline compliance for EU clinical laboratories using SOPHiA GENETICS’ products. This initiative introduces an efficient digital solution […]
Genomics England select QIAGEN’s Clinical Knowledge Base to power first-of-its-kind whole-genome sequencing study for newborns National study will screen newborns for more than 200 treatable conditions to help identify appropriate treatments that are accessible for all in England Clinically relevant variant content from QIAGEN will be used to support evidence-based variant interpretation and reporting results […]
New capability delivers enhanced performance for high-throughput single cell experiments SEATTLE — Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today announced a significant expansion of its Evercode™ WT Mega Kit functionality. Researchers can now analyze up to 384 samples and 1 million cells in a single run, unlocking new possibilities […]
Software upgrade advances complete workflow solutions New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable newly released Illumina Single-Cell Prep Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X […]
This bisulfite-free method of methylation detection is updated with a faster, more streamlined workflow that enables highly sensitive methylation analysis with as little as 100 pg input. IPSWICH, Mass. — New England Biolabs (NEB®) announces the launch of EM-seq™ v2, a high-performance enzyme-based alternative to bisulfite sequencing for the identification of 5mC and 5hmC. The enzyme-based […]
BILLERICA, Mass.–Bruker Corporation (Nasdaq: BRKR) today commented on the ruling of the U.S. District Court for the District of Delaware in the case involving GeoMx® Digital Spatial Profiler products sold by its NanoString business. Yesterday, the Court issued its ruling on the post-trial motions that followed the November 2023 jury verdict in the patent infringement […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
